MDVLQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MDVLQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. MedAvail Holdings's Revenue for the three months ended in Jun. 2023 was $0.41 Mil. MedAvail Holdings's average Accounts Receivable for the three months ended in Jun. 2023 was $0.25 Mil. Hence, MedAvail Holdings's Receivables Turnover for the three months ended in Jun. 2023 was 1.62.
The historical data trend for MedAvail Holdings's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedAvail Holdings Annual Data | |||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | |||||
Receivables Turnover | 9.06 | 14.43 | 16.34 | 25.37 |
MedAvail Holdings Quarterly Data | |||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | |
Receivables Turnover | Get a 7-Day Free Trial | 0.28 | 5.28 | 5.08 | 0.51 | 1.62 |
For the Pharmaceutical Retailers subindustry, MedAvail Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, MedAvail Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where MedAvail Holdings's Receivables Turnover falls into.
Receivables Turnover measures the number of times a company collects its average accounts receivable balance.
MedAvail Holdings's Receivables Turnover for the fiscal year that ended in Dec. 2022 is calculated as
Receivables Turnover (A: Dec. 2022 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (A: Dec. 2022 ) | / ( | (Accounts Receivable (A: Dec. 2021 ) | + | Accounts Receivable (A: Dec. 2022 )) | / | count ) |
= | 43.109 | / ( | (1.189 | + | 2.209) | / | 2 ) |
= | 43.109 | / | 1.699 | ||||
= | 25.37 |
MedAvail Holdings's Receivables Turnover for the quarter that ended in Jun. 2023 is calculated as
Receivables Turnover (Q: Jun. 2023 ) | |||||||
= | Revenue | / | Average Total Inventories | ||||
= | Revenue (Q: Jun. 2023 ) | / ( | (Accounts Receivable (Q: Mar. 2023 ) | + | Accounts Receivable (Q: Jun. 2023 )) | / | count ) |
= | 0.405 | / ( | (0.207 | + | 0.292) | / | 2 ) |
= | 0.405 | / | 0.2495 | ||||
= | 1.62 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedAvail Holdings (OTCPK:MDVLQ) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Thank you for viewing the detailed overview of MedAvail Holdings's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Ramona Seabaugh | officer: Chief Financial Officer | C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4 |
Michael R Kramer | director | 3910 BRICKWAY BLVD, SANTA ROSA CA 95403 |
Paul D Johnson | director | 440 N BARRANCA AVE #3550, COVINA CA 91723 |
Glen D. Stettin | director | C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121 |
Mark Edward Doerr | director, officer: Chief Executive Officer | C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4 |
Abg Wtt-medavail Ltd | 10 percent owner | 15 QUEENS ROAD CENTRAL, UNIT 3002-3004, 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK, HONG KONG F4 0000000000 |
Redco Ii Master Fund, L.p. | director, 10 percent owner | ONE LETTERMAN DRIVE, BLDG D, STE D3-300, SAN FRANCISCO CA 94129 |
Alyeska Fund Gp, Llc | 10 percent owner | 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601 |
Alyeska Investment Group, Llc | 10 percent owner | 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601 |
Alyeska Investments, Llc | 10 percent owner | 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601 |
Anand Parekh | 10 percent owner | 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601 |
Alyeska Master Fund, L.p. | 10 percent owner | 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601 |
Alyeska Investment Group, L.p. | 10 percent owner | 77 WEST WACKER DRIVE, 7TH FLOOR, CHICAGO IL 60601 |
Steven Hess | officer: Executive Vice President | C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4 |
Edwin Kilroy | director, officer: Chief Executive Officer | C/O MEDAVAIL TECHNOLOGIES INC., 6665 MILLCREEK DR, UNIT 1, MISSISSAUGA A6 L5N 5M4 |
From GuruFocus
By sperokesalga sperokesalga • 05-15-2023
By Marketwired • 08-04-2023
By sperokesalga sperokesalga • 05-15-2023
By Marketwired • 08-30-2023
By GuruFocus Research • 02-07-2024
By sperokesalga sperokesalga • 03-17-2023
By sperokesalga sperokesalga • 04-12-2023
By Business Wire Business Wire • 10-27-2022
By Marketwired • 08-14-2023
By sperokesalga sperokesalga • 03-30-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.